Takeda AIMI: how Takeda's medical information AI agent keeps answers accurate

Source read October 26, 2026: the Salesforce customer story on Takeda, dated September 14, 2026. It is a vendor’s story with Takeda’s input, and it publishes no accuracy figures.

Pharma medical information agents keep answers accurate by drafting only from approved sources, citing each source, and leaving the final answer to a medical information professional. Takeda’s public description of its AIMI agent says staff enter the product and the healthcare professional’s question, the agent finds relevant information and prepares a citation backed response, and Takeda’s medical information professionals remain responsible for reviewing, validating and delivering it. No accuracy figures are published.

How Takeda’s AIMI medical information agent keeps answers accurate

Takeda’s AI Medical Information Agent, AIMI, helps its medical information team answer questions from healthcare professionals (HCPs), such as questions on efficacy, safety, dosing and administration. The accuracy design, as described, has three parts. Answers are grounded in a fixed library of regulated documents. Each suggested answer comes with its source citations. A medical information professional reviews every answer before it goes out.

That is the same shape I see in most early generative AI work in pharma: the AI drafts and a qualified person decides. I wrote about why these uses show up first in Where GenAI shows up first. AIMI and its sibling agent SEIMEI are logged in the Pharma AI Tracker with the source and the date.

What Takeda says AIMI and SEIMEI do

Everything in this section comes from one source, the Salesforce customer story on Takeda dated September 14, 2026 (archived copy). The deployment record is in the Pharma AI Tracker entry for SEIMEI and AIMI.

“When an inquiry is received, the staff member enters the product and the HCP’s question, and AIMI helps find relevant medical information and prepare a citation-backed response. Takeda’s internal medical information professionals remain responsible for reviewing the evidence, validating the content, and delivering the final response.”

Salesforce customer story on Takeda, September 14, 2026, read October 26, 2026

“It then surfaces a suggested response with specific source citations. Medical staff review every response for accuracy and compliance before sending it to the HCP.”

Same source, on how AIMI uses retrieval augmented generation (RAG), archived September 28, 2026

“SEIMEI processes the PDF-based clinical literature and internal documents, extracting and surfacing key findings. Then, the analyst can review and verify the content and sources and direct the agent to compile the information as needed.”

Same source, on SEIMEI (Smart Expertise in Medical Insights), read October 26, 2026

The story adds a few more details. More than 3,100 regulated documents, including clinical study reports and prescribing information, are ingested from Veeva Vault. AIMI inquiries “are logged and auditable”, and “permissions restrict users to authorized information”. The story says AIMI has supported staff with over 25,000 HCP medical information requests. Those are counts of use, not measures of accuracy.

Beyond Takeda’s AIMI: the controls any medical information agent needs

Takeda’s description covers the core. When I look at a medical information agent, these are the controls I want to see, in the order I check them:

1. An approved source library. The agent retrieves only from documents that medical review has approved, with a named owner and a version for each one. If a document is withdrawn, it leaves the library the same day.
2. A citation for every claim. Each statement in a suggested answer points to the passage it came from, so the reviewer checks the passage, not their memory.
3. A refusal when no source fits. If retrieval finds nothing relevant, the agent says so and routes the question to a person. A fluent answer with no source is the failure I worry about most.
4. A named human who signs off. The reviewer is a qualified medical information professional, and the record shows who approved each answer and when.
5. Review that stays real. If reviewers accept almost every draft unchanged, I would sample answers and check them independently, because a rubber stamp looks the same as a good review in the logs.
6. A log of each answer. Keep the question, the sources retrieved, the draft, the human edits and the final answer. I described the fields for the model call itself in an audit trail for LLM calls.
7. Access that matches the question. The agent sees only what the user is allowed to see, by country and audience, so an answer for one market does not cite content approved for another.
8. A test set before launch and after each change. A fixed set of real past questions with agreed answers, rerun whenever the model, the prompt or the library changes.

Takeda’s story describes the first, second, fourth, sixth and seventh of these. It does not say whether the others exist, which is not the same as saying they are missing.

What is not published

The story gives no accuracy rate, no error rate and no share of drafts that reviewers changed. It does not say how AIMI was tested or whether it is treated as a validated system. It also does not say what happens when no relevant source is found. I would not infer any of those from a customer story, and I would not repeat a number for them until Takeda or Salesforce publishes one.

If you are designing review for a medical information agent and want to talk through the controls, get in touch.

Frequently asked questions

Does Takeda publish AIMI's accuracy?

No. The September 14, 2026 Salesforce customer story on Takeda gives counts of use, such as over 25,000 HCP medical information requests supported, but no accuracy rate, error rate or edit rate. The accuracy design it describes is approved sources, citations on each suggested answer and review of every response by medical staff before it is sent.

Who is responsible for an AIMI answer?

Takeda’s own medical information professionals. The customer story says they “remain responsible for reviewing the evidence, validating the content, and delivering the final response”. AIMI finds relevant information and prepares a citation backed draft. A person decides what the healthcare professional receives, which keeps accountability where medical information teams have always had it.

Which AI is most accurate for medical information?

I don’t know of a neutral, published benchmark for pharma medical information agents, so I would not name a product. Accuracy in this setting depends more on the controls than on the model: an approved source library, a citation for each claim, a refusal when no source fits, and a qualified reviewer who signs off on each answer.

I’m not affiliated with Takeda. This piece is based on public sources.